Parkinson's disease: recent development in therapies for advanced disease with a focus on deep brain stimulation (DBS) and duodenal levodopa infusion
- PMID: 18279380
- DOI: 10.1111/j.1742-4658.2008.06295.x
Parkinson's disease: recent development in therapies for advanced disease with a focus on deep brain stimulation (DBS) and duodenal levodopa infusion
Abstract
Effective medical treatment for Parkinson's disease has been available for almost 40 years. After several years of treatment with L-dihydroxyphenylalanine (L-dopa, levodopa), however, fluctuations often occur. The patient may then experience random variations of the motor symptoms during the day. The medication becomes increasingly complicated. New therapeutic methods, deep brain stimulation and duodenal infusion of L-dopa, have proven to be very effective in stabilizing the fluctuations. A clinical update of Parkinson's disease is presented together with a short review of these two methods.
References
-
- Daniel SE & Lees AJ (1993) Parkinson’s Disease Society Brain Bank, London: overview and research. J Neural Transm 39, 165-172.
-
- Scherfler C, Schwarz J, Antonini A, Grosset D, Valldeoriola F, Marek K, Oertel W, Tolosa E, Lees AJ & Poewe W (2007) Role of DAT-SPECT in the diagnostic work up of Parkinsonism. Mov Disord 22, 1229-1238.
-
- Carlsson A, Lindqvist M & Magnusson T (1957) 3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists. Nature 180, 1200.
-
- Cotzias GC, Van Woert MH & Schiffer LM (1967) Aromatic amino acids and modification of parkinsonism. N Engl J Med 276, 374-379.
-
- Cotzias GC, Papavasiliou PS & Gellene R (1969) L-dopa in parkinson’s syndrome. N Engl J Med 281, 272.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
